跳至主要内容
临床试验/NCT04837833
NCT04837833进行中(未招募)不适用

Machine Learning Approach to Sonographic Assessment of Tumor Volumes for Response Assessment in Patients With Pancreas or Gastrointestinal Adenocarcinoma: A Pilot Study

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2021年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
19
试验地点
2
主要终点
measurement differences between ultrasound tumor volumes

研究概览

简要总结

The purpose of this study is to see if ultrasound images that are analyzed by a special computer program can be used to measure the size of PDAC tumors in the liver as accurately as CT scans that involve contrast material (also called contrast-enhanced CT scans). All participants in this study will have pancreatic ductal adenocarcinoma (PDAC) that has spread (metastasized) to the liver, and all participants will be scheduled for a routine CT scan that will measure their cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients, 18 years of age or older
  • Confirmed diagnosis of PDAC or GI tract adenocarcinoma metastatic to liver
  • Scheduled for imaging with contrast enhanced CT

排除标准

  • Inability to tolerate intravenous contrast medium
  • All liver metastases ≤ 10 mm in maximal diameter on the contrast enhanced CT used for comparison to the planned research ultrasound
  • Multiple confluent liver metastases or tumor burden > 50% of the liver as estimated by a radiologist

结局指标

主要结局

measurement differences between ultrasound tumor volumes

时间窗: 1 year

Measure the range of volumetric changes of liver metastases observed between rUS1 and rUS2. We will correlate the rate (%) of tumor volumetric change between the rUS1 and rUS2 to the rate of change between the two CECT.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验